MedPath

Impact of skin to skin contact alert device on parent complaince to KMC in low birth weight babies between 1.5-2.5kgs compared to kangaro mother care

Not yet recruiting
Conditions
Condition originating in the perinatal period, unspecified,
Registration Number
CTRI/2023/07/055500
Lead Sponsor
Jawaharlal nehru medical college ,belgaum
Brief Summary

Kangaroo mother care (KMC), sometimes called skin-to-skin care, is a technique of

newborn care where babies are kept skin-to-skin with a parent, typically their mother. It

is most used for Low Birth-Weight preterm babies. It ensures warmth to preterm/LBW

improves breast feeding, prevents infection and it also reduces hospital stay.

Participation of your child will help us to assess the compliance to kangaroo mother care

which promotes better weight gain, early breast feeding and early discharge.

We will divide into two groups in which one will receive "KANGA SURAKSHA" device and

other group will receive routine kangaroo mother care.

In the study you may be included in any one of the groups. If you are selected in the

intervention group you will receive the "KANGA SURAKSHA" device.

As a mother you may not practice KMC properly, you may not know when the baby

becomes cold, hence in this study the device detects hypothermia, which will alert you

to put your baby in skin-to-skin contact. This device monitors whether the baby is in

skin-to-skin contact or not, weight of the baby and checks temperature with an alarm.

This information will be obtained on phone, which will help us to monitor your

compliance to KMC and alert you when required. By practicing KMC for a longer time,

we expect that you will be able to practice breastfeeding better and in turn your baby

gains better weight. Practicing KMC will also help in early discharge.

However, we will be calling you for regular follow ups every week to monitor the weight

gain, breastfeeding, and other problems which we do routinely for all the babies in KMC.

This monitoring will be done till the baby attains 2.5kgs or 40 weeks. You will be given a dairy to note down the no. breast feeds, mode of feeding, temperature and duration of

KMC being practiced.

If you are selected in the control group you will be providing conventional KMC care to

your baby. You will be manually monitoring temperature and weight gain of your baby

as per the instructions of health care providers.

Routine monitoring of the babies in both the groups will be done by the health care

providers (Doctors and nurses) as a part of NICU care for preterm and Low birth weight

babies with KMC.

As in the intervention group weekly follow up of the babies in the control group will be

done in the KMC clinic. A self-reporting dairy similar to the interventional group would

be provided to the mothers, data of which would be collected on scheduled follow ups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Impact of skin to skin contact alert device KANGA SURAKSHA on parent complaince to KMC in low birth weight babies between 1.5-2.5kgs compared to conventional kangaro mother care a one year hospital based RCT.

Exclusion Criteria

1 Infants not clinically stable or who had major congenital malformation will be excluded 2 Mother with debilitating ilness who would not be able to provide KMC 3 Those who are not willing to give consent are also excluded from study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This KANGA SURAKSHA device will increase complainace to KMC for more than 10hours The study will be conducted over a span of one yearThe study will be conducted over a span of one year
Secondary Outcome Measures
NameTimeMethod
1 will promote better weight gain in LBW babies compared to conventional kangaroo mother care2 will improve breast feeding in babies compared to conventional kangaroo mother care

Trial Locations

Locations (1)

KLE prabhakar kore

🇮🇳

Belgaum, KARNATAKA, India

KLE prabhakar kore
🇮🇳Belgaum, KARNATAKA, India
Dr Palle Nikitha
Principal investigator
7416531363
nikithapalle1898@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.